Clinical Trial Update: Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation). [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic characterization of the fentanyl iontophoretic transdermal system (40 mcg per activation); the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• FENTANYL (FENTANYL)

Snippet

Sponsor: Incline Therapeutics, Inc. | Conditions: Pain, Postoperative | Phase 1 | Status: COMPLETED